Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient
Open Access
- 29 August 2014
- journal article
- case report
- Published by Springer Nature in Parasites & Vectors
- Vol. 7 (1) , 1-3
Abstract
Cutaneous leishmaniasis (CL) is one of the common tropical protozoal diseases caused by various Leishmania species, and transmitted by the sand-fly vectors, Phlebotomus and Lutzomyia species. Herein, we report for the first time a case of CL that presented as large eczematous plaques occurring on the dorsi of both feet in a Libyan drug addicted, alcoholic patient with HIV infection. A 34 year-old HIV-positive, alcoholic, drug addicted Libyan male presented to us with a history of a non-itchy skin lesions on the dorsi of both feet of 5-weeks duration. Systemic and topical antibiotics were given without improvement. Diagnosis of this patient was confirmed by observation of Leishmania amastigote bodies in stained slit-skin smear skin biopsy. After parenteral administration of sodium stiboglyconate (Pentostam) (20 mg/kg/day) for 28 days the lesions did not show any marked improvement. Concurrently, combination therapy of oral rifampicin (600 mg/day) and isoniazide (300 mg/day) was given for 8 weeks. Complete healing of lesions was achieved after this treatment and skin-slit smears turned negative. Localized cutaneous leishmaniasis should be remembered in deferential diagnosis of unresponsive contact dermatitis especially for HIV-positive patients in CL endemic areas. This patient was not responding to Pentostam therapy, which is not very common in Libya. Interestingly, combination of oral rifampicin (600 mg/day) and isoniazide (300 mg/day) can be a successful alternative therapy.Keywords
This publication has 16 references indexed in Scilit:
- First Molecular Epidemiological Study of Cutaneous Leishmaniasis in LibyaPLOS Neglected Tropical Diseases, 2012
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- Control of the leishmaniases.2010
- Diffuse cutaneous leishmaniasis: Co-infection with human immunodeficiency virus (HIV)Indian Journal of Dermatology, Venereology and Leprology, 2008
- Leishmaniaand HIV co-infection: dermatological manifestationsPathogens and Global Health, 2003
- Cutaneous leishmaniasis: an overview.Journal of Postgraduate Medicine, 2003
- CLINICAL PICTURE OF CUTANEOUS LEISHMANIASIS IN ISFAHAN, IRANInternational Journal of Dermatology, 1994
- Clinical diagnosis of cutaneous leishmaniasis (oriental sore)Journal of the American Academy of Dermatology, 1987
- Rifampicin Treatment of Cutaneous LeishmaniasisInternational Journal of Dermatology, 1982
- POTENTIATING ACTION OF RIFAMPICIN AND ISONIAZID AGAINST LEISHMANIA MEXICANA AMAZONENSISThe Lancet, 1981